Bousmah MA, Protopopescu C, Mpoudi-Etame M, Bassega PO, et al. Improvements in patient-reported outcomes following initiation of dolutegravir- or low-dose efavirenz-based first-line antiretroviral therapy: A four-year longitudinal analysis in Cameroon (NAMSAL ANRS 12313 trial). J Acquir Immune Defic Syndr 2023 Aug 14. doi: 10.1097/QAI.0000000000003273.
PMID: 37643413